This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-262945-zfcz0hpd | COVID-19: is it just a lung disease? |
| cord-337026-osgi06o4 | Can the coronavirus disease 2019( COVID-19) affect the eyes? |
| cord-284734-qioy7eso | Intravenous immunoglobulin treatment of the post- polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up Mumps; use of convalescent serum in the treatment and prophylaxis of orchitis The prophylactic use of measles convalescent serum Use of convalescent measles serum to control measles in a preparatory school Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-265293-l9omunq4 | A novel syndrome? |
| cord-265293-l9omunq4 | Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-298980-yt52bgc7 | Is it safe to continue therapy during the pandemic? |
| cord-298980-yt52bgc7 | Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period? |
| cord-276132-tv5y1eqc | Do patients with cancer have a poorer prognosis of COVID-19? |
| cord-273829-t5cuop5c | Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia Clinical features of COVID-19 in elderly patients: a comparison with young and middle- aged patients Diagnosis of the coronavirus disease( COVID-19): rRT- PCR or CT? |
| cord-261222-762nqkbg | a multi- centre retrospective study Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19 Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States[ published correction appears in Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID-19 Admission hyperglycemia and radiological findings of SARS- CoV2 in patients with and without diabetes Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control? |
| cord-348121-c7jq240j | Le mascherine fanno venire il cancro? |
| cord-289115-bntcn0m6 | 2020 Patients of COVID-19 may benefit from sustained lopinavir- combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression COVID-19: risk for cytokine targeting in chronic inflammatory diseases? |
| cord-289115-bntcn0m6 | : What should we expect? |
| cord-289115-bntcn0m6 | : what do we know? |
| cord-341987-lsvifqyo | Neonatal early- onset infection with SARS- CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan Perinatal transmission of COVID-19 associated SARS- CoV-2: should we worry? |
| cord-341987-lsvifqyo | The impact of the current SARS- CoV-2 pandemic on neonatal care Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Coronavirus disease 2019( COVID-19) in neonates and children from China: a review Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome Coronavirus infection and pregnancy Impact of COVID-19 on neonatal health: are we causing more harm than good? |
| cord-254631-80sg4uvd | Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years? |
| cord-303959-e1654g5j | : what do we know? |
| cord-029137-mck5cmn7 | ( VAP) caused by resistant gram- negative bacteria: which is the best strategy to treat? |
| cord-029137-mck5cmn7 | a multicentre prospective observational study in the intensive care setting Is there a future for tigecycline? |
| cord-317956-srbualjc | COVID-19: the gendered impacts of the outbreak The gendered dimensions of COVID-19 COVID-19 patients'clinical characteristics, discharge rate, and fatality rate of meta- analysis Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection Lifelong gender gap in risk of incident myocardial infarction: the Tromsø study Sex differences in cardiovascular disease and cognitive impairment: another health disparity for women? |
| cord-303731-yrlzxtbw | Mosby MASA, the Mann assessment of swallowing ability To cough or not to cough? |
| cord-303731-yrlzxtbw | a case series Dysphagia in COVID-19-multilevel damage to the swallowing network? |
| cord-351531-wo1ggmmn | COVID-19 pneumonia: ARDS or not? |
| cord-285748-us5do6c2 | 2 infection by detection of nucleocapsid protein Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China Single- cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: a potential pathway of COVID-19 infection Outbreak of chronic renal failure: will this be a delayed heritage of COVID-19? |
| cord-285748-us5do6c2 | Does the interaction between viral S1 protein and ACE2 has an impact on the systematic or renal local RAS system? |
| cord-285748-us5do6c2 | If yes, does the treatment of CKD patients need to be adjusted? |
| cord-285748-us5do6c2 | SARS- CoV-2 mainly distributes in proximal tubular epithelium and podocytes which triggered some interesting questions: Does the use of ACEIs/ ARBs lead to increased ACE2 expression and subsequently enhance viral entry? |
| cord-300866-cso6l6ze | Is the occurrence of cerebral hemorrhage in patients related to the consumption of ACE2 by SARS- CoV-2? |
| cord-300866-cso6l6ze | Nevertheless, are patients with type A more likely to develop cerebrovascular accidents after SARS- CoV-2 infection? |
| cord-310084-taaz6mhs | Deep vein thrombosis and pulmonary embolism: two complications of COVID-19 pneumonia? |
| cord-310084-taaz6mhs | MedRxiv Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-310084-taaz6mhs | a retrospective case series study Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report New coronavirus pneumonia prevention and control program Global action plan on physical activity 2018- 2030: more active people for a healthier world: World Health Organization Ischemic and hemorrhagic strokes in Dakar, Senegal: a hospitalbased study Presumed asymptomatic carrier transmission of COVID-19 Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines SARS- CoV-2: olfaction, brain infection, and the urgent need for clinical samples allowing earlier virus detection COVID-19 and stroke: casual or causal role? |
| cord-312730-4ejjmab4 | When will it be over?": an introduction to viral reproduction numbers, R 0 and R e. |
| cord-295041-5vpawtef | ( SARS- CoV-2) Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host- virus interaction, and proposed neurotropic mechanisms Can the enteric nervous system be an alternative entrance door in SARS- CoV2 neuroinvasion? |
| cord-295041-5vpawtef | A mechanism of virus- induced demyelination Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-295041-5vpawtef | COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role? |
| cord-295041-5vpawtef | How Covid-19 can damage the brain Neurological manifestations in severe acute respiratory syndrome Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-295041-5vpawtef | More Prevalent Than Acknowledged? |
| cord-295041-5vpawtef | causative or coincidental? |
| cord-344217-kci4uw7u | Coronaviruses of man Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus Occurrence and frequency of coronavirus infections in humans as determined by enzyme- linked immunosorbent assay Human coronaviruses: what do they cause? |
| cord-344217-kci4uw7u | Emerg Infect Dis Wet markets- a continuing source of severe acute respiratory syndrome and influenza? |
| cord-338544-eph89g47 | COVID-19: is it just a lung disease? |
| cord-338544-eph89g47 | Int Forum Allergy Rhinol Guillain Barre syndrome associated with COVID-19 infection: a case report Guillain- Barré syndrome following COVID-19: new infection, old complication? |
| cord-269425-e9iyso7n | Could antiphospholipid antibodies contribute to coagulopathy in COVID-19? |
| cord-269425-e9iyso7n | Why do patients with immune thrombocytopenia( ITP) experience lower bleeding events despite thrombocytopenia? |
| cord-269425-e9iyso7n | causation or correlation? |
| cord-340305-jtvn9tlm | As the authors suggest, are these examples simply ones of persistence or re- infection? |
| cord-340305-jtvn9tlm | Does neutralization antibody ensure protection? |
| cord-340305-jtvn9tlm | How would this dilemma then be potentially overcome? |
| cord-340305-jtvn9tlm | If neutralizing antibody correlates with protection, is there a threshold at which the prediction can be confident? |
| cord-340305-jtvn9tlm | viral relapse, reinfection or inflammatory rebound? |